DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
| User | Tweets |
|---|---|
| @Tickeron | 8 |
| @AmericanBanking | 4 |
| @OlympiaReport | 4 |
| @ThisLincolnian | 3 |
| @WeekHerald | 3 |
Recent Tweets for CYTK
 |
@AmericanBanking Robert I. Blum Sells 6,000 Shares of Cytokinetics, Inc. $CYTK Stock https://t.co/Yw8OVYFkw4 #stocks September 17th 2019, 5:09pm |
 |
@fintel_io Insider Blum Robert I reports selling 6,000 shares of $CYTK for a total cost of $76,469.40 (CLICK TO SEE TRADING P… https://t.co/UYZa7DxWuA September 17th 2019, 5:09pm |
 |
@InsiderAlertsIA $CYTK: New Insider Filing on President & CEO ROBERT I BLUM: https://t.co/LYsn5vWCjz September 17th 2019, 5:09pm |
 |
@stocknewstimes Cytokinetics $CYTK Given a $23.00 Price Target at JMP Securities https://t.co/hLZxiWTU58 September 17th 2019, 3:09am |
 |
@TranscriptDaily Cytokinetics $CYTK Given a $23.00 Price Target at JMP Securities https://t.co/TVEjzc0zS9 September 17th 2019, 3:09am |
 |
@TheMarketsDaily Cytokinetics $CYTK Given a $23.00 Price Target at JMP Securities https://t.co/J8ckw2YFfJ September 17th 2019, 3:09am |
 |
@Tickeron $CYTK in Uptrend: 50-day Moving Average moved above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/IB1ZghZ3Xc September 16th 2019, 11:09pm |
 |
@Gambiste1 RT @AlexBo6: @IlliniJJ did you miss $CYTK , huge amount of data to consume , but no improvement in earnings ..a bitter pill September 16th 2019, 6:09pm |
 |
@AlexBo6 @IlliniJJ did you miss $CYTK , huge amount of data to consume , but no improvement in earnings ..a bitter pill September 16th 2019, 4:09pm |
 |
@MarketCurrents $CYTK - Cytokinetics up 4% on positive early-stage data on CK-274 https://t.co/stsxqv19cW September 16th 2019, 12:09pm |
 |
@biostockinfo RT @InsiderBiotech: $CYTK CYTOKINETICS ANNOUNCES DATA FROM PHASE 1 STUDY OF CK-3773274 The study met its primary and secondary objectives t… September 16th 2019, 9:09am |
 |
@InsiderBiotech $CYTK CYTOKINETICS ANNOUNCES DATA FROM PHASE 1 STUDY OF CK-3773274 The study met its primary and secondary objectiv… https://t.co/pCRawhLJYo September 16th 2019, 9:09am |
 |
@syinvesting $CYTK announced positive data from the Ph 1 study of CK-274 in oHCM. These data support the advancement of CK-274 i… https://t.co/mFxQuzs4eZ September 16th 2019, 9:09am |
 |
@VisualStockRSRC $CYTK - Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23?? Annual Scientific https://t.co/XHXEdWsWTm September 16th 2019, 7:09am |
 |
@TickerReport JMP Securities Raises Cytokinetics $CYTK Price Target to $23.00 https://t.co/XWfH9a6a7y September 16th 2019, 5:09am |
|
@TickerReport Zacks Investment Research Upgrades Cytokinetics $CYTK to “Hold” https://t.co/VeHsNaib1I September 16th 2019, 2:09am |
|
@AmericanBanking Cytokinetics $CYTK – Analysts’ Weekly Ratings Updates https://t.co/407fLeimYC #stocks September 16th 2019, 2:09am |
 |
@dailypoliticaln Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/SLtillUwFo September 14th 2019, 3:09pm |
 |
@ZolmaxNews Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/ZZwhRtNQJE September 14th 2019, 3:09pm |
 |
@WatchlistN Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/1OXT0ilRha September 14th 2019, 3:09pm |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average moved above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/kBc00pkxSS September 14th 2019, 1:09am |
|
@dakotafinancial Traders Purchase Large Volume of Cytokinetics Put Options $CYTK https://t.co/sL7MKypEYf September 13th 2019, 11:09pm |
|
@AmericanBanking Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/ZQ4N2s4AyD #stocks September 13th 2019, 5:09pm |
 |
@OlympiaReport Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/784TpqETd6 September 13th 2019, 5:09pm |
 |
@WeekHerald Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/bEllNGiXg4 September 13th 2019, 5:09pm |
 |
@ThisLincolnian Cytokinetics Target of Unusually High Options Trading $CYTK https://t.co/sFyU76PCMi September 13th 2019, 5:09pm |
 |
@grostz $CYTK looks like a badly managed version of $MYOK. Science is good, but they made some very bad decisions, like goi… https://t.co/MXt6pBa28B September 13th 2019, 3:09pm |
|
@WeekHerald Cytokinetics $CYTK Upgraded by Zacks Investment Research to Hold https://t.co/xWh3LZjNTt September 13th 2019, 1:09pm |
|
@OlympiaReport Cytokinetics $CYTK Raised to Hold at Zacks Investment Research https://t.co/4StlSdFcKz September 13th 2019, 1:09pm |
 |
@dispatchtribune Cytokinetics $CYTK Upgraded by Zacks Investment Research to Hold https://t.co/OgrYfiOZSe September 13th 2019, 1:09pm |
|
@AmericanBanking Cytokinetics $CYTK Given New $23.00 Price Target at JMP Securities https://t.co/amGQWacAdS #stocks September 13th 2019, 8:09am |
 |
@Quantumup1 $CYTK PT raised to $23, keeps a Buy rating at JMP Securities https://t.co/0Jf9KNVFXP September 13th 2019, 7:09am |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/diGDxrRP0n September 12th 2019, 10:09pm |
 |
@bbnsnews Cytokinetics $CYTK Upgraded to Hold by Zacks Investment Research https://t.co/9TmKWLof4O September 12th 2019, 9:09pm |
 |
@MC_OptionTrades $CYTK 20-Sep-19 Straddle Implies a ±7.6% move. Sep 13 23rd Annual HFSA Scientific Meeting https://t.co/RAQCvG1R6t September 12th 2019, 4:09pm |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average broke above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/tBacPgWRCR September 11th 2019, 11:09pm |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/ArQ6v23qx2 September 10th 2019, 10:09pm |
|
@TranscriptDaily Cytokinetics’ $CYTK “Overweight” Rating Reiterated at Cantor Fitzgerald https://t.co/NslkI6DpcE September 10th 2019, 5:09am |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/5HPyeFOLIM September 9th 2019, 9:09pm |
 |
@Cytokinetics $CYTK investors: Today our CEO Robert Blum presented at the Morgan Stanley Healthcare Conference. Tomorrow he will… https://t.co/TvpebbCUw3 September 9th 2019, 3:09pm |
 |
@IlliniJJ $CYTK - looks like some folks jumping off ahead of data. September 9th 2019, 1:09pm |
 |
@AlertTrade TREND REVERSAL DOWN ALERT: $CYTK Cytokinetics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room September 9th 2019, 11:09am |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average broke above 200-day Moving Average on April 10, 2019. View odds for this an… https://t.co/j4OZxGxlYv September 8th 2019, 8:09pm |
 |
@ConsumerFeed Cantor Fitzgerald Reaffirms “Overweight” Rating for Cytokinetics $CYTK https://t.co/xGFWr2hlQr September 8th 2019, 12:09pm |
|
@TickerReport Cytokinetics $CYTK Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/gV9ztSewCl September 8th 2019, 12:09pm |
|
@OlympiaReport Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/Unj4NeETqe September 8th 2019, 12:09pm |
|
@WeekHerald Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/NoKP1fgXWT September 8th 2019, 12:09pm |
|
@ThisLincolnian Cytokinetics $CYTK Upgraded at Zacks Investment Research https://t.co/aVh34II4DS September 8th 2019, 11:09am |
|
@Tickeron $CYTK in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on April 10, 2019. View odds for this… https://t.co/xzJ8Y1OeoS September 7th 2019, 9:09pm |
|
@OlympiaReport Cytokinetics $CYTK Given Overweight Rating at Cantor Fitzgerald https://t.co/a9EDpLJH3N September 7th 2019, 11:09am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.